Target intelligence / Profile preview

ZBTB46 antisense RNA 2 (ZBTB46-AS2)

Target: ZBTB46-AS2
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

ZBTB46 antisense RNA 2 (ZBTB46-AS2) is a long non-coding RNA transcribed from the antisense strand of the ZBTB46 gene locus. It is annotated in genomic databases (e.g., NCBI Gene accession NR_186425.1) but, unlike the ZBTB46 protein-coding gene, there is little peer-reviewed evidence regarding its function, expression profile, or involvement in disease. There is currently no evidence to suggest that ZBTB46-AS2 serves as a direct therapeutic target, biomarker, or is involved in any validated biological pathways or drug interactions. Its function remains to be characterized.

Beyond the preview

Go deeper on ZBTB46 antisense RNA 2 (ZBTB46-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZBTB46 antisense RNA 2 (ZBTB46-AS2).

Explore the full profile